Canine CKD is far more insidious than its feline counterpart — dogs rarely show clinical signs until 75% of nephron mass is lost, and by then, the window for intervention is narrow. This course covers IRIS staging in depth, the critical differences between canine and feline CKD management, evidence-based phosphorus and proteinuria control, and the integrative adjuncts with the strongest clinical rationale. We follow Murphy, a 10-year-old Labrador Retriever, from first elevated SDMA through end-of-life planning. Earn 1.0 RACE CE credit.
Opening case: Murphy, a 10-year-old intact male Labrador Retriever, presenting for routine wellness with mild PU/PD. His owner says he seems fine — but his labs tell a different story.
The critical differences between canine and feline CKD staging, SDMA as the early biomarker, UPC substaging, blood pressure substaging, and why the canine kidney fails so quietly
Evidence-based intervention targets, first-line therapies, dosing protocols for telmisartan and ACE inhibitors, when to add phosphate binders, and the blood pressure monitoring protocol that actually works in practice
10 questions · Passing score: 70%
Complete all course modules to unlock the assessment. Upon passing, your CE certificate will be generated automatically.
Subcutaneous fluid therapy in dogs, renal diet selection and limitations, protein restriction controversy, potassium supplementation, appetite stimulants, anemia management, and the B-vitamin repletion protocol
Omega-3 dosing and evidence, probiotics and the uremic toxin problem, acupuncture points for renal support, Chinese herbal formulas with renal applications, and the gut-kidney axis in dogs
Quality-of-life assessment tools, when to shift from management to comfort, the conversation owners need before the crisis, and Murphy's 18-month follow-up